{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T20:56:38Z","timestamp":1693428998220},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T00:00:00Z","timestamp":1473292800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00105-016-3871-6","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T08:02:21Z","timestamp":1473321741000},"page":"774-779","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Schleimhautbeteiligung bei blasenbildenden Autoimmunerkrankungen"],"prefix":"10.1007","volume":"67","author":[{"given":"C.","family":"G\u00fcnther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,8]]},"reference":[{"issue":"8","key":"3871_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00105-015-3644-7","volume":"66","author":"C Gunther","year":"2015","unstructured":"Gunther C, Beissert S (2015) Lupus erythematosus. Hautarzt 66(8):611\u2013616. doi: 10.1007\/s00105-015-3644-7","journal-title":"Hautarzt"},{"key":"3871_CR2","first-page":"844","volume":"9","author":"A Kneisel","year":"2011","unstructured":"Kneisel A, Hertl M (2011) Autoimmune bullous skin diseases. Part 1: Clinical manifestations. J\u00a0Dtsch Dermatol Ges 9:844\u2013856","journal-title":"J Dtsch Dermatol Ges"},{"key":"3871_CR3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332","journal-title":"Lancet"},{"key":"3871_CR4","first-page":"844","volume":"9","author":"A Kneisel","year":"2011","unstructured":"Kneisel A, Hertl M (2011) Autoimmune bullous skin diseases. Part 1: Clinical manifestations. J\u00a0Dtsch Dermatol Ges 9:844\u2013856","journal-title":"J Dtsch Dermatol Ges"},{"key":"3871_CR5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/jid.2015.54","volume":"135","author":"DA Culton","year":"2015","unstructured":"Culton DA, McCray SK, Park M et al (2015) Mucosal pemphigus vulgaris anti-Dsg3 IgG is pathogenic to the oral mucosa of humanized Dsg3 mice. J Invest Dermatol 135:1590\u20131597","journal-title":"J Invest Dermatol"},{"key":"3871_CR6","first-page":"713","volume":"13","author":"E Schmidt","year":"2015","unstructured":"Schmidt E, Goebeler M, Hertl M et\u00a0al (2015) S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J\u00a0Dtsch Dermatol Ges 13:713\u2013727","journal-title":"J Dtsch Dermatol Ges"},{"key":"3871_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10753-014-0023-y","volume":"38","author":"RM Shamsabadi","year":"2015","unstructured":"Shamsabadi RM, Basafa S, Yarahmadi R et\u00a0al (2015) Elevated expression of NLRP1 and IPAF are related to oral pemphigus vulgaris pathogenesis. Inflammation 38:205\u2013208","journal-title":"Inflammation"},{"key":"3871_CR8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00105-015-3656-3","volume":"66","author":"R Eming","year":"2015","unstructured":"Eming R (2015) Pemphigus. Model disease for targeted therapy. Hautarzt 66:574\u2013582","journal-title":"Hautarzt"},{"key":"3871_CR9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI28547","volume":"116","author":"M Hertl","year":"2006","unstructured":"Hertl M, Eming R, Veldman C (2006) T cell control in autoimmune bullous skin disorders. J\u00a0Clin Invest 116:1159\u20131166","journal-title":"J Clin Invest"},{"key":"3871_CR10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1610-0387.2005.05722.x","volume":"3","author":"F Mayrshofer","year":"2005","unstructured":"Mayrshofer F, Hertl M, Sinkgraven R et\u00a0al (2005) Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group. J\u00a0Dtsch Dermatol Ges 3:431\u2013435","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"3871_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bjd.14405","volume":"175","author":"C Boulard","year":"2016","unstructured":"Boulard C, Duvert LS, Picard-Dahan C et al (2016) Calculation of cut-off values based on the ABSIS and PDAI pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus. Br J Dermatol 175(1):142\u2013149. doi: 10.1111\/bjd.14405","journal-title":"Br J Dermatol"},{"key":"3871_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14877","author":"L Maier","year":"2016","unstructured":"Maier L, Udvardi A, Hertl M et al (2016) Paraneoplastic pemphigus with anti-BP180 autoantibodies and Castleman\u2019s disease. Br J Dermatol. doi: 10.1111\/bjd.14877","journal-title":"Br J Dermatol"},{"key":"3871_CR13","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","volume":"340","author":"HC Nousari","year":"1999","unstructured":"Nousari HC, Deterding R, Wojtczack H et\u00a0al (1999) The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 340:1406\u20131410","journal-title":"N Engl J Med"},{"key":"3871_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1684\/ejd.2016.2772","volume":"26","author":"X Li","year":"2016","unstructured":"Li X, Qian H, Sogame R et\u00a0al (2016) Integrin beta4 is a major target antigen in pure ocular mucous membrane pemphigoid. Eur J Dermatol 26:247\u2013253","journal-title":"Eur J Dermatol"},{"key":"3871_CR15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oooo.2015.03.012","volume":"120","author":"A Sultan","year":"2015","unstructured":"Sultan A, Stojanov IJ, Lerman MA et\u00a0al (2015) Oral lichen planus pemphigoides: A series of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol 120:58\u201368","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"3871_CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1523-1747.1999.00618.x","volume":"113","author":"D Zillikens","year":"1999","unstructured":"Zillikens D, Caux F, Mascaro JM et al (1999) Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C\u2011terminal NC16A domain of BP180. J Invest Dermatol 113:117\u2013121","journal-title":"J Invest Dermatol"},{"key":"3871_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.2009.00793.x","volume":"37","author":"T Dainichi","year":"2010","unstructured":"Dainichi T, Koga H, Tsuji T et al (2010) From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. J Dermatol 37:231\u2013238","journal-title":"J Dermatol"},{"key":"3871_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1667-2","author":"MS Alrashdan","year":"2016","unstructured":"Alrashdan MS, Cirillo N, McCullough M (2016) Oral lichen planus: A literature review and update. Arch Dermatol Res. doi: 10.1007\/s00403-016-1667-2","journal-title":"Arch Dermatol Res"},{"key":"3871_CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000018257","volume":"199","author":"M Skaria","year":"1999","unstructured":"Skaria M, Salomon D, Jaunin F et\u00a0al (1999) IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180. Dermatology 199:253\u2013255","journal-title":"Dermatology"},{"key":"3871_CR20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2133.1989.tb08215.x","volume":"121","author":"SM Burge","year":"1989","unstructured":"Burge SM, Frith PA, Juniper RP et\u00a0al (1989) Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol 121:727\u2013741","journal-title":"Br J Dermatol"},{"key":"3871_CR21","first-page":"376","volume":"18","author":"MM Nico","year":"2008","unstructured":"Nico MM, Vilela MA, Rivitti EA et\u00a0al (2008) Oral lesions in lupus erythematosus: Correlation with cutaneous lesions. Eur J Dermatol 18:376\u2013381","journal-title":"Eur J Dermatol"},{"key":"3871_CR22","first-page":"927","volume":"9","author":"A Kneisel","year":"2011","unstructured":"Kneisel A, Hertl M (2011) Autoimmune bullous skin diseases. Part 2: Diagnosis and therapy. J\u00a0Dtsch Dermatol Ges 9:927\u2013947","journal-title":"J Dtsch Dermatol Ges"},{"key":"3871_CR23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00105-007-1432-8","volume":"58","author":"C Gunther","year":"2007","unstructured":"Gunther C, Hertl M, Meurer M (2007) Diagnostic use of autoantibodies. Hautarzt 58:1063\u20131074","journal-title":"Hautarzt"},{"key":"3871_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0190-9622(03)01830-9","volume":"50","author":"C Gunther","year":"2004","unstructured":"Gunther C, Wozel G, Meurer M et\u00a0al (2004) Topical tacrolimus treatment for cicatricial pemphigoid. J\u00a0Am Acad Dermatol 50:325\u2013326","journal-title":"J Am Acad Dermatol"},{"key":"3871_CR25","first-page":"833","volume":"13","author":"R Eming","year":"2015","unstructured":"Eming R, Sticherling M, Hofmann SC et\u00a0al (2015) S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J\u00a0Dtsch Dermatol Ges 13:833\u2013844","journal-title":"J Dtsch Dermatol Ges"},{"key":"3871_CR26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1610-0387.2008.06605.x","volume":"6","author":"C Gunther","year":"2008","unstructured":"Gunther C, Laske J, Frind A et\u00a0al (2008) Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorb adsorber. J\u00a0Dtsch Dermatol Ges 6:661\u2013663","journal-title":"J Dtsch Dermatol Ges"},{"key":"3871_CR27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","volume":"302","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Zillikens D (2010) Immunoadsorption in dermatology. Arch Dermatol Res 302:241\u2013253","journal-title":"Arch Dermatol Res"},{"key":"3871_CR28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00347-008-1700-8","volume":"105","author":"T Meyer-ter-Vehn","year":"2008","unstructured":"Meyer-ter-Vehn T, Schmidt E, Zillikens D et al (2008) Mucous membrane pemphigoid with ocular involvement. Part II: Therapy. Ophthalmologe 105:405\u2013419","journal-title":"Ophthalmologe"},{"key":"3871_CR29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-4632.2010.04707.x","volume":"50","author":"S Schulz","year":"2011","unstructured":"Schulz S, Deuster D, Schmidt E et al (2011) Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid. Int J Dermatol 50:1129\u20131131","journal-title":"Int J Dermatol"},{"key":"3871_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jtos.2013.02.003","volume":"11","author":"B Sobolewska","year":"2013","unstructured":"Sobolewska B, Deuter C, Zierhut M (2013) Current medical treatment of ocular mucous membrane pemphigoid. Ocul Surf 11:259\u2013266","journal-title":"Ocul Surf"},{"key":"3871_CR31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08916934.2011.606447","volume":"45","author":"M Kasperkiewicz","year":"2012","unstructured":"Kasperkiewicz M, Zillikens D, Schmidt E (2012) Pemphigoid diseases: Pathogenesis, diagnosis, and treatment. Autoimmunity 45:55\u201370","journal-title":"Autoimmunity"},{"key":"3871_CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","volume":"33","author":"M Kasperkiewicz","year":"2007","unstructured":"Kasperkiewicz M, Zillikens D (2007) The pathophysiology of bullous pemphigoid. Clinic Rev Allerg Immunol 33:67\u201377","journal-title":"Clinic Rev Allerg Immunol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3871-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3871-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3871-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T21:15:46Z","timestamp":1601068546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3871-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3871"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3871-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,8]]}}}